| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Executive Chairman | Director +2 more
2 companies
Murphy Keith serves as a Director at HURA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 4 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2020 | HURA Tuhura Biosciences, Inc./nv | Director | Buy | 181,010 | $0.00 | - | New | |
| Nov 24, 2017 | VIVS Vivosim Labs, Inc. | Former Affiliate Last Filing | Buy | 335,500 | $1.49 | $501,306.50 | +5.6% | |
| Feb 9, 2017 | VIVS Vivosim Labs, Inc. | Chairman, CEO And President | Sale+OE | 25,000 | $3.68 | $92,035.00 | -0.4% | |
| Jan 24, 2017 | VIVS Vivosim Labs, Inc. | Chairman, CEO And President | Sell | 25,000 | $3.51 | $87,655.62 | -0.4% | |
| Dec 14, 2016 | VIVS Vivosim Labs, Inc. | Chairman, CEO And President | Sell | 50,000 | $3.72 | $185,955.00 | -0.8% | |
| Aug 12, 2015 | VIVS Vivosim Labs, Inc. | Chairman, CEO And President | Buy | 20,000 | $2.56 | $51,188.00 | +0.3% |